We found that regardless of gender (male or female), smoking history (current/former or never smoker), tumor diameter (> 10 or ≤ 10 mm), and tumor pathological subtype (AIS/MIA or IAC), the EGFR mutation rate showed an increasing trend with the decrease of GGO component (Fig. 4 B-E).
← all excerpts
The correlation between EGFR mutation status and clinicopathological characteristics, Ki67 expression and immune cell infiltration in lung adenocarcinoma with different radiological subtypes.
1
—
—